Hispanic patients with IBD at increased risk for hospitalization, surgery

Hispanic patients treated with biologic agents for inflammatory bowel diseases face a greater risk for hospitalization, surgery and infections compared with non-Hispanic patients, according to a study in Clinical Gastroenterology and Hepatology.“Hispanic patients have been underrepresented in clinical trials of biologic agents in IBD, and hence, there is limited data on effectiveness and safety of…